Inbiotec: Instituto de biotecnología de León

Inbiotec: Instituto de biotecnología de León
Website enhancements to better serve you. It will be fully available soon.
  • 18 Feb 2016 | 0:00 h

    Past February 17, the results of the European project MySterI (Mycobacterial Steroids for Industry) were presented for the final-term defence by its project coordinator, the researcher from the INBIOTEC team, Dr. Carlos Barreiro. It was the project’s final meeting with the ERA-IB secretariat and more than 70 scientists, with the aim to justify a successfully developed project encompassing partners from Russia, Norway, Germany, UK and Spain. MySterI has been aimed at producing high value steroid precursors using a novel bioconversion strategy resulting in lower production and environmental costs.

    Latest news

    • On April 5th, INBIOTEC attended the follow up meeting of the European project SCILS (http://www.era-ib.net/scils), held in Berlin. The session was integrated as a satellite meeting of the 4th International BioProScale Symposium and Exhibition (http:/
    • One more year, INBIOTEC, as associate member, attended the partnering event organized by the Bio-based Industries Consortium, the private side in the European Public-Private Partnership on Bio-based Industries (BBI) between the European Commission an
    • The second week of February Hyderabad and Bangalore were visited by INBIOTEC as member of the mission that CDTI (Spain) and DBT (India) organized in order to foster technological cooperation between both countries. Together with a group of Spanish co